2-deoxy-2-fluorogalactose has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibby, BM; Frisch, K; Keiding, S; Mikkelsen, KS; Sørensen, M; Villadsen, GE | 1 |
| Frisch, K; Keiding, S; Mikkelsen, KS; Sørensen, M; Villadsen, GE | 1 |
2 other study(ies) available for 2-deoxy-2-fluorogalactose and Liver Cirrhosis
| Article | Year |
|---|---|
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Topics: Adult; Aged; Algorithms; Data Interpretation, Statistical; Female; Fucose; Galactose; Humans; Linear Models; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Veins | 2014 |
Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fucose; Galactokinase; Humans; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |